| Nom |
5,5-DIHYDRO-5-MÉTHYL-6-(1,5-DIMÉTHYL-6-HYDROXY-4-(PHOSPHORYLOXY)TRIDECA-7,9,11-TRIENYL)-2H-PYRAN-2-ONE (SEL DE SODIUM) |
| Synonymes |
CYTOSTATINE ; CYTOSTATINE (SEL DE SODIUM) ; 5,6-DIHYDRO-5-MÉTHYL-6-[1,5-DIMÉTHYL-6-HYDROXY-4-(PHOSPHORYLOXY)-(7Z, 9Z, 11E)-TRIDECA-7,9,11-TRIENYL]-2H-PYRAN-2-ONE SEL DE SODIUM ; hydrogénophosphate de sodium (4E,6E,8E)-3-hydroxy-2-méthyl-1-[3-(3-méthyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)butyl]déca-4,6,8-trien-1-yl ; (4E,6E,8E)-3-hydroxy-2-méthyl-1-[3-(3-méthyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)butyl]déca-4,6,8-trien-1-yl dihydrophosphate ; hexane-3,4-diyldibenzène-4,1-diylbis[dihydrogène (phosphate)] |
| Nom anglais |
5,5-DIHYDRO-5-METHYL-6-(1,5-DIMETHYL-6-HYDROXY-4-(PHOSPHORYLOXY)TRIDECA-7,9,11-TRIENYL)-2H-PYRAN-2-ONE (SODIUM SALT);CYTOSTATIN; CYTOSTATIN (SODIUM SALT); 5,6-DIHYDRO-5-METHYL-6-[1,5-DIMETHYL-6-HYDROXY-4-(PHOSPHORYLOXY)-(7Z, 9Z, 11E)-TRIDECA-7,9,11-TRIENYL]-2H-PYRAN-2-ONE SODIUM SALT; sodium (4E,6E,8E)-3-hydroxy-2-methyl-1-[3-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)butyl]deca-4,6,8-trien-1-yl hydrogen phosphate; (4E,6E,8E)-3-hydroxy-2-methyl-1-[3-(3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)butyl]deca-4,6,8-trien-1-yl dihydrogen phosphate; hexane-3,4-diyldibenzene-4,1-diyl bis[dihydrogen (phosphate)] |
| Formule moléculaire |
C18H24O8P2 |
| Poids Moléculaire |
430.3259 |
| InChI |
InChI=1/C18H24O8P2/c1-3-17(13-5-9-15(10-6-13)25-27(19,20)21)18(4-2)14-7-11-16(12-8-14)26-28(22,23)24/h5-12,17-18H,3-4H2,1-2H3,(H2,19,20,21)(H2,22,23,24) |
| Numéro de registre CAS |
156856-30-3 |
| Structure moléculaire |
|
| Densité |
1.417g/cm3 |
| Point d'ébullition |
618.108°C at 760 mmHg |
| Indice de réfraction |
1.592 |
| Point d'éclair |
327.62°C |
| Pression de vapeur |
0mmHg at 25°C |
| Les symboles de danger |
|
| Codes des risques |
|
| Description de sécurité |
|
|
FR
CN
CZ
DE
EN
ES
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR
